{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:57:28Z","timestamp":1769752648161,"version":"3.49.0"},"reference-count":26,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijdvl.ijdvl_425_16","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T11:14:25Z","timestamp":1497438865000},"page":"441","source":"Crossref","is-referenced-by-count":15,"title":["Atorvastatin as adjunctive therapy for chronic plaque type psoriasis versus betamethasone valerate alone: A randomized, double-blind, placebo-controlled trial"],"prefix":"10.25259","volume":"83","author":[{"given":"SharleneHelene H.","family":"Chua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GiselleMarie S.","family":"Tioleco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CarmelaAugusta F.","family":"Dayrit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WinloveP","family":"Mojica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BelenL","family":"Dofitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LornaF","family":"Frez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.206714-1","unstructured":"Gudjonsson JE, Elder JT. Psoriasis. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York, McGraw-Hill; 2008. p. 169-93."},{"key":"key-10.4103\/0378-6323.206714-2","first-page":"1959","volume-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","author":"Ridker","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0378-6323.206714-3","first-page":"230","volume-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein.The Cholesterol and Recurrent Events (CARE) Investigators","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"key-10.4103\/0378-6323.206714-4","first-page":"64","volume-title":"Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation\/CRP evaluation (PRINCE): A randomized trial and cohort study","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"key-10.4103\/0378-6323.206714-5","first-page":"1685","volume-title":"Inflammatory markers, cholesterol and statins: Pathophysiological role and clinical importance","author":"Biasucci","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"key-10.4103\/0378-6323.206714-6","first-page":"529","volume-title":"Efficacy of simvastatin in plaque psoriasis: A pilot study","author":"Shirinsky","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.206714-7","first-page":"411","volume-title":"Simvastatin in psoriasis: Ambiguous effects","author":"Colsman","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.206714-8","first-page":"58","volume-title":"The remarkable beneficial effect of adding oral simvastatin to topical betamethasone for treatment of psoriasis: A double-blind, randomized, placebo-controlled study","author":"Naseri","year":"2010","journal-title":"Niger J Med","ISSN":"https:\/\/id.crossref.org\/issn\/1115-2613","issn-type":"print"},{"key":"key-10.4103\/0378-6323.206714-9","first-page":"37","volume-title":"Possibilities of atorvastatin in complex management of extensive psoriasis in patients with arterial hypertension","author":"Vasiuk","year":"2010","journal-title":"Kardiologiia"},{"key":"key-10.4103\/0378-6323.206714-10","first-page":"13","volume-title":"A randomized, double-blind, placebo-controlled trial on the efficacy of simvastatin in the treatment of chronic plaque type psoriasis","author":"Guitan","year":"2012","journal-title":"J Philipp Dermatol Soc"},{"key":"key-10.4103\/0378-6323.206714-11","first-page":"1045","volume-title":"Atorvastatin for the treatment of plaque-type psoriasis","author":"Faghihi","year":"2011","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/0378-6323.206714-12","first-page":"394","volume-title":"Clinical improvement in psoriasis with treatment of associated hyperlipidemia","author":"Ghazizadeh","year":"2011","journal-title":"Am J Med Sci"},{"key":"key-10.4103\/0378-6323.206714-13","first-page":"45","volume-title":"Comparison of quality of life questionnaires and their correlation with the clinical course of patients with psoriasis","author":"Torres","year":"2011","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/0378-6323.206714-14","unstructured":"Finlay A. (Personal communication with the author through e-mail, May 26, 2012)."},{"key":"key-10.4103\/0378-6323.206714-15","first-page":"561","volume-title":"Psoriasis and dyslipidaemia: A population-based study","author":"Dreiher","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.206714-16","first-page":"68","volume-title":"Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study","author":"Gisondi","year":"2007","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.206714-17","first-page":"152","volume-title":"Association between psoriasis and the metabolic syndrome.A cross-sectional study","author":"Cohen","year":"2008","journal-title":"Dermatology"},{"key":"key-10.4103\/0378-6323.206714-18","first-page":"664","volume-title":"A review of high-dose statin therapy: Targeting cholesterol and inflammation in atherosclerosis","author":"Patel","year":"2007","journal-title":"Eur Heart J"},{"key":"key-10.4103\/0378-6323.206714-19","first-page":"451","volume-title":"Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: Results of a randomized, double-blind, placebo-controlled study","author":"Macin","year":"2005","journal-title":"Am Heart J"},{"key":"key-10.4103\/0378-6323.206714-20","first-page":"161","volume-title":"Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients","author":"Ascer","year":"2004","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0378-6323.206714-21","first-page":"2015","volume-title":"Trial of atorvastatin in rheumatoid arthritis (TARA): Double-blind, randomised placebo-controlled trial","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"key-10.4103\/0378-6323.206714-22","first-page":"357","volume-title":"The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value","author":"Lewandowski","year":"2008","journal-title":"Cardiol J"},{"key":"key-10.4103\/0378-6323.206714-23","first-page":"859","volume-title":"A 50% reduction in the psoriasis area and severity index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis","author":"Carlin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.206714-24","doi-asserted-by":"crossref","unstructured":"Finlay AY, Khan GK. Dermatology life quality index (DLQI) \u2013 A simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.25.","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"key-10.4103\/0378-6323.206714-25","first-page":"71","volume-title":"The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: Results of a phase II study","author":"Shikiar","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"key-10.4103\/0378-6323.206714-26","first-page":"700","volume-title":"C-reactive protein in psoriasis: A review of the literature","author":"Beygi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:44:15Z","timestamp":1611917055000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/atorvastatin-as-adjunctive-therapy-for-chronic-plaque-type-psoriasis-versus-betamethasone-valerate-alone-a-randomized-double-blind-placebo-controlled-trial\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["206714"],"URL":"https:\/\/doi.org\/10.4103\/ijdvl.ijdvl_425_16","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}